1. Augustin, Ryan C, Bao, Riyue, Luke, Jason J. . Targeting Cbl-b in cancer immunotherapy. In Journal for immunotherapy of cancer, 11, . doi:10.1136/jitc-2022-006007. https://pubmed.ncbi.nlm.nih.gov/36750253/
2. Mueller, Stefanie H, Lai, Alvina G, Valkovskaya, Maria, Hamann, Ute, Kuchenbaecker, Karoline B. 2023. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. In Genome medicine, 15, 7. doi:10.1186/s13073-022-01152-5. https://pubmed.ncbi.nlm.nih.gov/36703164/
3. Yokoi, Norihide, Komeda, Kajuro, Wang, He-Yao, Serikawa, Tadao, Seino, Susumu. 2002. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. In Nature genetics, 31, 391-4. doi:. https://pubmed.ncbi.nlm.nih.gov/12118252/
4. Kumar, Jitendra, Kumar, Ritesh, Kumar Singh, Amir, Davila, Marco L, Venuprasad, K. . Deletion of Cbl-b inhibits CD8+ T-cell exhaustion and promotes CAR T-cell function. In Journal for immunotherapy of cancer, 9, . doi:10.1136/jitc-2020-001688. https://pubmed.ncbi.nlm.nih.gov/33462140/
5. You, Hongjun, Chang, Fengjun, Chen, Haichao, Wang, Yi, Han, Wenqi. 2024. Exploring the role of CBLB in acute myocardial infarction: transcriptomic, microbiomic, and metabolomic analyses. In Journal of translational medicine, 22, 654. doi:10.1186/s12967-024-05425-y. https://pubmed.ncbi.nlm.nih.gov/39004726/
6. Song, Jing, Anderson, Warren, Hu, Alex, Rawlings, David J, Buckner, Jane H. 2022. CBLB Deficiency in Human CD4+ T Cells Results in Resistance to T Regulatory Suppression through Multiple Mechanisms. In Journal of immunology (Baltimore, Md. : 1950), 209, 1260-1271. doi:10.4049/jimmunol.2200219. https://pubmed.ncbi.nlm.nih.gov/36165179/
7. Jack, J, Small, G W, Brown, C C, Motsinger-Reif, A A, Richards, K L. 2017. Gene expression and linkage analysis implicate CBLB as a mediator of rituximab resistance. In The pharmacogenomics journal, 18, 467-473. doi:10.1038/tpj.2017.41. https://pubmed.ncbi.nlm.nih.gov/29205205/
智鼠故事 
